What should a respiratory therapist do if a patient shows bilateral expiratory wheezing and experiences nausea and tremors with beta-agonist medication?

• A. Monitor carefully and notify the nurse and physician
• B. Direct the patient to breathe at a slower rate
• C. Reduce future doses to half-strength
• D. Immediately discontinue the treatment and notify the physician

Answer: (D)

If a patient demonstrates bilateral expiratory wheezing alongside symptoms like nausea and tremors after receiving beta-agonist medication, the most appropriate action is to discontinue the treatment and inform the physician. This response is crucial because the presence of these symptoms indicates that the patient may be experiencing adverse effects or complications related to the medication.

Beta-agonists are commonly used to relieve bronchospasm; however, significant side effects can occur, especially if the medication is not tolerated well by the patient. The wheezing suggests that the medication may not be providing the intended bronchodilation or could even be causing bronchial irritation. Nausea and tremors further indicate that the patient is experiencing systemic effects from the beta-agonist, suggesting that continuing the treatment may pose additional risks.

Immediate discontinuation of the medication protects the patient's safety and allows healthcare professionals to re-evaluate the treatment plan. Notifying the physician is essential so that they can assess the situation and consider alternative interventions or medications that might be safer and more effective for the patient. This coordinated response helps ensure that the patient receives appropriate care while minimizing potential harm.